Skip to main content

Table 3 Geometric mean concentration (GMC, μg /ml) and 95 % confidence intervals (CI) of antibodies against pneumococcal serotypes included in the 11-valent pneumococcal vaccine given at 6, 10 and 14 weeks of age in Filipino infants

From: Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants

Age 1 3 4 5 6B 7F 9V 14 18C 19F 23F
6 wk
(n = 49)
0.48 (0.34–0.68) 0.40 (0.30–0.54) 0.27 (0.19–0.38) 0.53 (0.37–0.77) 0.33 (0.24–0.46) 0.80 (0.58–1.12) 0.53 (0.39–0.77) 1.54 (1.03–2.53) 0.38 (0.26–0.52) 0.96 (0.64–1.45 0.49 (0.35–0.73)
18 wk
(n = 47)
15.23 (12.75–18.19) 4.87 (3.91–6.08) 23.41 (18.95–28.92) 12.49 (10.77–14.48) 1.12 (0.77–1.61) 8.87 (6.82–11.53) 7.69 (6.27–9.43) 2.18 (1.65–2.87) 4.50 (3.18–6.38) 16.11 (12.81–20.24) 3.89 (2.83–5.34)
  1. Serum sample withdrawn before vaccination at 6 weeks of age and 4 weeks after the third dose at 18 weeks of age